S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Kuehn Law Launches Inquiry into Viking Therapeutics Leadership

Shareholders of Viking Therapeutics, Inc. are under scrutiny as New York-based firm Kuehn Law, PLLC investigates potential breaches of fiduciary duty by the company’s officers and directors. The inquiry centers on allegations of self-dealing, opening a window for investors to seek damages or demand corporate governance reforms.

Kuehn Law Launches Inquiry into Viking Therapeutics Leadership
Photo: Bio & News

The investigation specifically targets whether internal leadership at the NASDAQ-listed firm prioritized personal interests over those of its investors. Kuehn Law has invited long-term VKTX stockholders to come forward, offering free consultations to evaluate potential claims. According to the firm, they cover all associated legal costs for participants, ensuring no financial burden falls on the investors themselves.

Those looking to participate or obtain more information are directed to reach out to Sophia Anne Silayan via email at [email protected] or by phone at (833) 672-0814. The firm emphasizes the urgency of the matter, citing time constraints for enforcing shareholder rights. This action follows the standard practice of derivative litigation aimed at addressing corporate conduct, though the firm notes that past legal successes are not indicative of future outcomes.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!